Nyxoah (NASDAQ:NYXH) used its fourth-quarter and full-year 2025 earnings call to outline the first results from the U.S. launch of its Genio hypoglossal nerve stimulation system, discuss the evolving ...
Earlier today, Hyperfine Inc. released financial results for the quarter ending December 31, 2025. Before we begin, I'd like ...
Aerolib launches Aerolib.app for Physician Advisors, featuring P2P simulations, IP-only search tools, & real-time ...
U.S. medical device companies seeking funding this year will find that innovative tech and a stand-out prototype aren’t ...
From idea to live app in minutes: a straightforward, five-step way to start building with AI—no coding experience needed.
(“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today ...
NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results